01—Abstract
Summary
Summary of the 10-K filed February 6, 2009. Cited figures are marked; the original filing is the authoritative source.
Intuitive Surgical Inc. (ISRG) presented a strong financial performance in its 2008 10-K filing, showcasing significant revenue growth driven by the increasing adoption of its da Vinci Surgical System.
The company reported a 46% increase in total revenue, reaching $874.9 milliona, with recurring revenue from instruments and accessories, and services, contributing 48% of the total. The installed base of da Vinci Surgical Systems grew to 1,111 units, facilitating approximately 136,000 procedures globally, with prostatectomies and hysterectomies being the dominant procedures. Despite a slowdown in system sales in the fourth quarter of 2008 due to the economic environment, the company maintained a healthy gross profit margin of 71% and a robust operating income of $310.8 million.
ISRG's financial position remained strong with $901.9 millionb in cash, cash equivalents, and investments. The company continues to invest heavily in research and development, indicating a commitment to innovation and maintaining market leadership in robotic-assisted surgery.
02—Key points
Key Highlights
- Total revenue grew 46% to $874.9 million in 2008, driven by strong adoption of the da Vinci Surgical System.
- Recurring revenue (instruments, accessories, services) increased 52% to $419.6 million, representing 48% of total revenue.
- Sold 335 da Vinci Surgical Systems in 2008, increasing the installed base to 1,111 systems.
- Performed approximately 136,000 surgical procedures globally in 2008, with prostatectomies (73,000) and hysterectomies (34,000) being the most common.
- Maintained strong gross profit margin of 71% and operating income of $310.8 million (36% of revenue).
- Ended the year with a substantial cash, cash equivalents, and investments balance of $901.9 million.
- Significantly increased R&D expenses by 62% to $79.4 million, reflecting investment in future product development and acquired intellectual property.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2008, Intuitive Surgical kept $0.23.
- Revenue$874.9M100.0%
- Cost of revenue−$254.1M29.0%
- Gross profit$620.8M71.0%
- Operating costs−$310.0M35.4%
- Operating income$310.8M35.5%
- Interest, other & tax−$106.5M12.2%
- Net income$204.3M23.4%
Where FY2008 revenue went
$874.9M- Cost of revenue: $254.1M, 29% of revenue
- SG&A: $230.6M, 26% of revenue
- Net income: $204.3M, 23% of revenue
- Interest, other & tax: $106.5M, 12% of revenue
- R&D: $79.4M, 9.1% of revenue
Kept 23% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2008filed February 6, 2009Financial Statements
FY2008 against FY2007
| Line item | FY2008FY2007 | Change |
|---|---|---|
| Revenue | $874.90M$600.83M | +45.6% |
| Cost of Revenue | $254.10M$186.54M | +36.2% |
| Gross Profit | $620.80M$414.29M | +49.8% |
| R&D Expenses | $79.40M$48.86M | +62.5% |
| SG&A Expenses | $230.60M$158.69M | +45.3% |
| Operating Expenses | $310.00M$207.54M | +49.4% |
| Operating Income | $310.80M$206.74M | +50.3% |
| Net Income | $204.30M$144.54M | +41.3% |
| EPS (Basic) | $0.58$0.42 | +37.7% |
| EPS (Diluted) | $0.57$0.41 | +38.4% |
| Shares Outstanding (Basic) | 350.10M340.48M | +2.8% |
| Shares Outstanding (Diluted) | 359.10M351.19M | +2.3% |
05—Questions
Frequently Asked Questions
What is the primary business of Intuitive Surgical Inc.?
Intuitive Surgical designs, manufactures, and markets the da Vinci Surgical System, an advanced robotic-assisted surgical system that enables surgeons to perform minimally invasive procedures with enhanced control, visualization, and dexterity.
What were the key financial drivers for Intuitive Surgical in 2008?
The primary financial drivers were the significant increase in sales of da Vinci Surgical Systems, the growing utilization of these systems leading to higher recurring revenue from instruments and accessories, and the expansion of service contracts. The company also saw strong growth in the number of procedures performed using its systems.
What is the company's strategy for future growth?
Intuitive Surgical's strategy is to establish da Vinci surgery as the standard approach for complex surgical procedures, aiming to displace traditional open surgery and standard minimally invasive surgery. Key elements include focusing on key procedures and institutions, leveraging leading surgeons for adoption, maintaining market leadership through technological enhancement, developing industry alliances, and increasing patient awareness.
What are the main risks identified by the company in its 10-K filing?
Key risks include achieving market acceptance for da Vinci surgery, the impact of economic conditions on customer spending, intense competition, long and variable sales cycles, manufacturing challenges, reliance on sole-sourced suppliers, regulatory hurdles, potential product liability claims, and the inability to protect intellectual property.
06—Continue